Old Web
English
Sign In
Acemap
>
authorDetail
>
RK Kelley
RK Kelley
University of Southern California
Cabozantinib
Medicine
Nuclear medicine
Internal medicine
Hepatocellular carcinoma
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CELESTIAL Studie: Steigerung qualitätskorrigierter Lebensjahre unter Cabozantinib Therapie bei Patienten mit fortgeschrittenem hepatozellulären Karzinom (HCC)
2019
Eckart Schott
P. Mollon
Tim Meyer
A-L Cheng
RK Kelley
AD Baron
Fawzi Benzaghou
V. Valcheva
S Hazra
Milan Mangeshkar
Nick Freemantle
Show All
Source
Cite
Save
Citations (0)
Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
2019
S Strasser
Ghassan K. Abou-Alfa
P Mollon
Tim Meyer
A-L Cheng
Anthony B. El-Khoueiry
RK Kelley
Ad Baron
Fawzi Benzaghou
Valcheva
Saswati Hazra
M. Mangeshkar
Nick Freemantle
Show All
Source
Cite
Save
Citations (0)
1